EMBL’s European Bioinformatics Institute (EMBL-EBI)
EMBL’s European Bioinformatics Institute (EMBL-EBI), founded in 1994, provides freely available data, bioinformatics services and training to the life science community worldwide.
EMBL-EBI is part of the European Molecular Biology Laboratory (EMBL), an intergovernmental research organisation funded by over 20 member states, prospect and associate member states.
EMBL-EBI’s co-location with the Wellcome Sanger Institute offers vital synergies. EMBL-EBI maintains the world’s most comprehensive range of molecular data resources, developed in collaboration with colleagues worldwide, and open to all.
EMBL-EBI provides advanced bioinformatics training to scientists at all levels.. EMBL-EBI’s face-to-face and on-demand training helps experimental and computational biologists make the most of the wide range of data resources available.
EMBL-EBI has been leading computational biology research since its inception, with deep involvement in large-scale endeavours such as the Human and Mouse Genome Projects, the Human Cell Atlas and publishing seminal works in structural biology, chemical biology and single-cell genomics.
An important part of EMBL-EBI’s mission is to disseminate cutting-edge technologies to industry. Since 1996, EMBL-EBI’s Industry Programme has been helping companies make the most of advances in bioinformatics and cheminformatics. The programme members include pharmaceutical, diagnostic,and agri-food companies. EMBL-EBI also encourages spin-outs with the help of its Technology Transfer office, EMBLEM.
EMBL-EBI’s funding comes from EMBL member states, the European Commission, the US National Institutes of Health, Wellcome, UK Research and Innovation and EMBL-EBI Industry Programme members.
Working at EMBL- EBI
Members of staff from 78 countries
website requests on an average day
collaborations with institutes across 52 countries
petabytes of raw data storage
Wellcome Sanger Institute
The Wellcome Sanger Institute is one of the premier centres of genomics research and innovation in the world.Learn more